Treating CCA cell lines with 200 nm GEM indicated (via γ‐H2AX assay) that CXCL6 knockdown aggravated drug‐induced DNA damage in both HuCCT1 and RBE cells (Figure S4A, Supporting Information). This evidence concerns the gene CXCL6 and cholangiocarcinoma.